Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy

Juan José Gallego1, Alessandra Fiorillo1, Franc Casanova-Ferrer1

  • 1Fundación de Investigación Hospital Clínico Universitario de Valencia-INCLIVA, 46010 Valencia, Spain.

Insights

Plasma extracellular vesicles (EVs) from patients with minimal hepatic encephalopathy (MHE) show altered cargo and promote inflammation. These EVs influence CD4+ T lymphocyte differentiation, suggesting a key role in MHE-associated immune changes.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Minimal hepatic encephalopathy (MHE) involves immune system alterations, including inflammation and changes in CD4+ T lymphocytes.
  • The precise mechanisms driving these immune changes in MHE are not fully understood.
  • Extracellular vesicles (EVs) carrying proteins and miRNAs are potential mediators of immune dysregulation.

Purpose of the Study:

  • To investigate the role of plasma EVs from MHE patients in inducing pro-inflammatory environments.
  • To assess the impact of MHE-derived EVs on CD4+ T lymphocyte differentiation.
  • To characterize the miRNA and protein cargo of plasma EVs in MHE.

Main Methods:

  • Plasma EVs were isolated and characterized from cirrhotic patients with and without MHE, and healthy controls.
  • CD4+ T cells from healthy donors were cultured with EVs from the study groups.
  • Cytokine release and CD4+ T cell subtype differentiation (Th17, Treg) were analyzed.

Main Results:

  • Plasma EVs from MHE patients exhibited distinct miRNA and protein profiles, enriched in inflammatory factors.
  • MHE-derived EVs modulated pro-inflammatory (IL-17, IL-21, TNF-α) and anti-inflammatory (TGF-β) cytokine expression in CD4+ T cells.
  • EVs from MHE patients increased the proportion of follicular T helper and regulatory T cells and enhanced Th17 cell activation.

Conclusions:

  • Plasma EVs play a significant role in mediating immune system changes observed in minimal hepatic encephalopathy.
  • Altered EV cargo in MHE contributes to a pro-inflammatory state and aberrant CD4+ T cell differentiation.
  • Targeting EVs may offer a therapeutic strategy for immune dysregulation in MHE.